H

Hualan Biological Bacterin Inc
SZSE:301207

Watchlist Manager
Hualan Biological Bacterin Inc
SZSE:301207
Watchlist
Price: 19.12 CNY -5.3% Market Closed
Market Cap: 11.5B CNY
Have any thoughts about
Hualan Biological Bacterin Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Hualan Biological Bacterin Inc

Current Assets 5.2B
Cash & Short-Term Investments 3B
Receivables 2B
Other Current Assets 201.7m
Non-Current Assets 2.8B
Long-Term Investments 1.3B
PP&E 1.2B
Intangibles 46.4m
Other Non-Current Assets 219.6m
Current Liabilities 1.7B
Accounts Payable 116.8m
Accrued Liabilities 1.2B
Short-Term Debt 300m
Other Current Liabilities 114m
Non-Current Liabilities 46.6m
Other Non-Current Liabilities 46.6m

Balance Sheet
Hualan Biological Bacterin Inc

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
143
279
412
115
600
641
Cash
141
275
81
115
600
641
Cash Equivalents
2
4
331
0
0
0
Short-Term Investments
210
222
453
826
1 608
2 392
Total Receivables
542
695
1 532
1 441
1 797
1 992
Accounts Receivables
540
689
1 530
1 439
1 796
1 990
Other Receivables
2
6
2
2
0
1
Inventory
78
56
45
107
167
173
Other Current Assets
15
10
23
40
79
449
Total Current Assets
988
1 262
2 465
2 529
4 193
5 227
PP&E Net
280
408
971
1 400
1 315
1 206
PP&E Gross
280
408
971
1 400
1 315
1 206
Accumulated Depreciation
282
333
366
418
543
678
Intangible Assets
33
37
42
44
45
46
Long-Term Investments
0
0
0
356
1 310
1 296
Other Long-Term Assets
67
87
170
194
213
220
Total Assets
1 368
N/A
1 794
+31%
3 648
+103%
4 523
+24%
7 076
+56%
7 995
+13%
Liabilities
Accounts Payable
20
15
34
161
110
117
Accrued Liabilities
2
2
15
930
1 050
1 155
Short-Term Debt
0
0
271
524
315
300
Current Portion of Long-Term Debt
0
0
0
1
0
0
Other Current Liabilities
459
514
1 134
56
61
114
Total Current Liabilities
481
531
1 455
1 672
1 537
1 686
Long-Term Debt
0
0
0
1
0
0
Deferred Income Tax
0
1
0
2
6
15
Other Liabilities
0
0
6
40
36
31
Total Liabilities
481
N/A
532
+11%
1 461
+175%
1 715
+17%
1 579
-8%
1 732
+10%
Equity
Common Stock
100
100
360
360
400
600
Retained Earnings
787
1 162
947
1 568
2 008
2 748
Additional Paid In Capital
0
0
880
880
3 089
2 915
Total Equity
887
N/A
1 262
+42%
2 187
+73%
2 808
+28%
5 497
+96%
6 263
+14%
Total Liabilities & Equity
1 368
N/A
1 794
+31%
3 648
+103%
4 523
+24%
7 076
+56%
7 995
+13%
Shares Outstanding
Common Shares Outstanding
400
400
600
600
600
600

See Also

Discover More